In a series of operations across Delhi, Uttar Pradesh, and Himachal Pradesh, Delhi's Anti-Narcotics Task Force (ANTF) busted ...

Akums Drugs and Pharmaceuticals Ltd., India’s largest contract development and manufacturing organization (CDMO), has ...

Here are three reasons why there are better opportunities than ANIP and a stock we'd rather own. 1. Fewer Distribution ...

The trial’s primary endpoint is the change in gout pain intensity from baseline in the target joint at day three.

ANI Pharma initiates phase 4 trial of purified Cortrophin Gel to treat acute gout flares: Princeton, New Jersey Friday, May 23, 2025, 14:00 Hrs [IST] ANI Pharmaceuticals, Inc., a ...

Sudeep Pharma Limited, a leading manufacturer of pharmaceutical and food-grade mineral ingredients, has announced the ...

Indian benchmark indices opened flat on Friday, showing signs of volatility mainly due to uncertain foreign portfolio ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amphastar ...

Pharmaceutical manufacturing encompasses all processes involved in the manufacturing and production of biological and medical products, botanical drugs, and herbs, as well as other pharmaceutical ...

Sun Pharmaceutical Industries Inc. (Sun Pharma), the fourth largest specialty generic pharmaceutical company globally, is offering a summer internship program in 2025 for students to gain ...

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2025 Earnings Call Transcript May 9, 2025 ANI Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.7, expectations were $1.37.